Abstract LB146: Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer

Abstract Cancer arises within a complex cellular milieu, where the extent and composition of tumor-infiltrating immune cells strongly influence tumor progression and patient prognosis. Emerging research highlights the therapeutic potential of fasting mimicking diets (FMDs) in delaying cancer onset, providing cellular protection and regulating immunity. My project investigates immune profiles, before and after the transfer of donor-derived immune cells previously exposed to fasting, either independently or combined with therapeutic drugs. We aim to identify immune populations, enhanced by this combined treatment, and to recognize their impact on tumor advancement and immune activation. Using the syngeneic 4T1, triple negative breast cancer mouse model, we evaluated how fasting and chemotherapy affect tumor growth and immune competence. Flow cytometry and immunohistochemistry were used to characterize immune cells, recruited at tumors, spleens and bone marrows of treated hosts. A subpopulation of preconditioned splenocytes and tumor-infiltrating lymphocytes, recognized through immunophenotyping, were transplanted into tumor-bearing recipients to assess tumor control, immune priming and cytotoxicity. We observed reduced tumor volume, delayed progression and increased survival rate in the transplants exposed to FMD and doxorubicin. The treatment preserved the size, morphology, and cellularity of healthy, primary and secondary lymphoid organs, while expanded beneficial, antitumor immune signatures. Integrating FMD with standard therapeutic strategies could enhance antitumor immunity and broaden the spectrum of malignancies that respond effectively. Exploring the underlying mechanisms may reveal immune pathways that can be therapeutically leveraged to eradicate tumors, in a field that currently remains unexplored. Citation Format: Evangelia Pavlou, Olga Blazevits, Giulia Salvadori, Sara Martone, Valter Longo. Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB146.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-17
DOI
https://doi.org/10.1158/1538-7445.am2026-lb146
Primary Topic
Dietary Effects on Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract LB146: Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer

Evangelia Pavlou, Olga Blaževitš, Sara Martone, Giulia Salvadori et al.
Cancer Research
Dietary Effects on Health
article

Abstract LB146: Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer

Evangelia Pavlou, Olga Blaževitš, Sara Martone, Giulia Salvadori, Valter Longo
article en

Abstract

Abstract Cancer arises within a complex cellular milieu, where the extent and composition of tumor-infiltrating immune cells strongly influence tumor progression and patient prognosis. Emerging research highlights the therapeutic potential of fasting mimicking diets (FMDs) in delaying cancer onset, providing cellular protection and regulating immunity. My project investigates immune profiles, before and after the transfer of donor-derived immune cells previously exposed to fasting, either independently or combined with therapeutic drugs. We aim to identify immune populations, enhanced by this combined treatment, and to recognize their impact on tumor advancement and immune activation. Using the syngeneic 4T1, triple negative breast cancer mouse model, we evaluated how fasting and chemotherapy affect tumor growth and immune competence. Flow cytometry and immunohistochemistry were used to characterize immune cells, recruited at tumors, spleens and bone marrows of treated hosts. A subpopulation of preconditioned splenocytes and tumor-infiltrating lymphocytes, recognized through immunophenotyping, were transplanted into tumor-bearing recipients to assess tumor control, immune priming and cytotoxicity. We observed reduced tumor volume, delayed progression and increased survival rate in the transplants exposed to FMD and doxorubicin. The treatment preserved the size, morphology, and cellularity of healthy, primary and secondary lymphoid organs, while expanded beneficial, antitumor immune signatures. Integrating FMD with standard therapeutic strategies could enhance antitumor immunity and broaden the spectrum of malignancies that respond effectively. Exploring the underlying mechanisms may reveal immune pathways that can be therapeutically leveraged to eradicate tumors, in a field that currently remains unexplored. Citation Format: Evangelia Pavlou, Olga Blazevits, Giulia Salvadori, Sara Martone, Valter Longo. Integrating a fasting mimicking diet to augment antitumor immunity following adoptive cell transfer in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(8_Suppl):Abstract nr LB146.

Cancer ResearchVol. 86(8_Supplement)
University of Southern California (US), IFOM (IT)
Good health and well-being
Openalex Percentile: Top 6%
Dietary Effects on Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.